Liu PH - Search Results

1

Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing.

Liu PH, Nair RG, Skinner CS, Murphy CC, Kim EJ, Ortiz C, Wang L, Hu E, Lykken JM, Levin TR, Green BB, Hahn EE, Santini N, Halm EA. Liu PH, et al. Cancer Epidemiol Biomarkers Prev. 2024 Feb 6;33(2):215-223. doi: 10.1158/1055-9965.EPI-23-0507. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 37964449 Free PMC article.

2

Persistent Disparities in Colorectal Cancer Screening: A Tell-Tale Sign for Implementing New Guidelines in Younger Adults.

Liu PH, Sanford NN, Liang PS, Singal AG, Murphy CC. Liu PH, et al. Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1701-1709. doi: 10.1158/1055-9965.EPI-21-1330. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35765830 Free PMC article.

3

Colorectal Cancer Screening Receipt Does Not Differ by 10-Year Mortality Risk Among Older Adults.

Liu PH, Singal AG, Murphy CC. Liu PH, et al. Am J Gastroenterol. 2024 Feb 1;119(2):353-363. doi: 10.14309/ajg.0000000000002536. Epub 2023 Oct 27. Am J Gastroenterol. 2024. PMID: 37782288

4

No Increase in Colorectal Cancer Screening in 2019 After American Cancer Society Recommends Starting Screening at Age 45.

Liu PH, Singal AG, Murphy CC. Liu PH, et al. Clin Gastroenterol Hepatol. 2023 Jul;21(7):1947-1949.e2. doi: 10.1016/j.cgh.2022.05.030. Epub 2022 Jun 11. Clin Gastroenterol Hepatol. 2023. PMID: 35700888 Free PMC article. No abstract available.

5

Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort.

Parikh ND, Tayob N, Al-Jarrah T, Kramer J, Melcher J, Smith D, Marquardt P, Liu PH, Tang R, Kanwal F, Singal AG. Parikh ND, et al. Among authors: liu ph. JAMA Netw Open. 2022 Jul 1;5(7):e2223504. doi: 10.1001/jamanetworkopen.2022.23504. JAMA Netw Open. 2022. PMID: 35867057 Free PMC article.

6

Hypochloremia as a novel adverse prognostic factor in acute liver failure.

Wang J, Liu PH, Xu P, Sumarsono A, Rule JA, Hedayati SS, Lee WM; Acute Liver Failure Study Group. Wang J, et al. Among authors: liu ph. Liver Int. 2022 Dec;42(12):2781-2790. doi: 10.1111/liv.15449. Epub 2022 Oct 17. Liver Int. 2022. PMID: 36203349 Free PMC article.

7

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis.

Marquardt P, Liu PH, Immergluck J, Olivares J, Arroyo A, Rich NE, Parikh ND, Yopp AC, Singal AG. Marquardt P, et al. Among authors: liu ph. Hepatol Commun. 2021 Sep;5(9):1481-1489. doi: 10.1002/hep4.1735. Epub 2021 May 4. Hepatol Commun. 2021. PMID: 34510836 Free PMC article.

8

An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan Criteria.

Ho SY, Liu PH, Hsu CY, Hsia CY, Su CW, Huang YH, Lei HJ, He YJ, Hou MC, Huo TI. Ho SY, et al. Among authors: liu ph. Am J Clin Oncol. 2019 Sep;42(9):698-704. doi: 10.1097/COC.0000000000000581. Am J Clin Oncol. 2019. PMID: 31335351

9

Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.

Ho SY, Hsu CY, Liu PH, Hsia CY, Su CW, Huang YH, Hou MC, Huo TI. Ho SY, et al. Among authors: liu ph. Eur J Surg Oncol. 2019 May;45(5):776-781. doi: 10.1016/j.ejso.2018.10.541. Epub 2018 Nov 1. Eur J Surg Oncol. 2019. PMID: 30401507

10

Predicting microvascular invasion in HCC with ctDNA: What are the pitfalls?

Huo TI, Ho SY, Liu PH. Huo TI, et al. Among authors: liu ph. Liver Int. 2021 May;41(5):1148-1149. doi: 10.1111/liv.14536. Epub 2020 Jun 8. Liver Int. 2021. PMID: 32449996 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters